DE602004002718D1 - Pharmazeutische Zusammensetzungen zur Behandlung von Herpes Zoster - Google Patents
Pharmazeutische Zusammensetzungen zur Behandlung von Herpes ZosterInfo
- Publication number
- DE602004002718D1 DE602004002718D1 DE602004002718T DE602004002718T DE602004002718D1 DE 602004002718 D1 DE602004002718 D1 DE 602004002718D1 DE 602004002718 T DE602004002718 T DE 602004002718T DE 602004002718 T DE602004002718 T DE 602004002718T DE 602004002718 D1 DE602004002718 D1 DE 602004002718D1
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- herpes zoster
- pharmaceutical composition
- pharmaceutical compositions
- ash
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 5
- 208000007514 Herpes zoster Diseases 0.000 title abstract 3
- 239000002956 ash Substances 0.000 abstract 2
- 229940099259 vaseline Drugs 0.000 abstract 2
- 239000005997 Calcium carbide Substances 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000010881 fly ash Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- CLZWAWBPWVRRGI-UHFFFAOYSA-N tert-butyl 2-[2-[2-[2-[bis[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]amino]-5-bromophenoxy]ethoxy]-4-methyl-n-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]anilino]acetate Chemical compound CC1=CC=C(N(CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)C(OCCOC=2C(=CC=C(Br)C=2)N(CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)=C1 CLZWAWBPWVRRGI-UHFFFAOYSA-N 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200300828 | 2003-04-08 | ||
| ES200300828A ES2216709B1 (es) | 2003-04-08 | 2003-04-08 | Composicion farmaceutica para tratar el herpes zoster. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE602004002718D1 true DE602004002718D1 (de) | 2006-11-23 |
| DE602004002718T2 DE602004002718T2 (de) | 2007-08-16 |
Family
ID=32982085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004002718T Expired - Lifetime DE602004002718T2 (de) | 2003-04-08 | 2004-04-05 | Pharmazeutische Zusammensetzungen zur Behandlung von Herpes Zoster |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1475096B1 (de) |
| AT (1) | ATE342060T1 (de) |
| DE (1) | DE602004002718T2 (de) |
| ES (1) | ES2216709B1 (de) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RO79426B1 (ro) * | 1982-02-23 | 1984-07-30 | Romulus Constantin Dinu | Compozitie medicamentoasa pentru tratamentul unor neuroviroze |
| US5476650A (en) * | 1994-03-17 | 1995-12-19 | Luster Products, Inc. | Conditioning and straightening hair relaxer |
| DE4431175A1 (de) * | 1994-09-01 | 1996-04-11 | Medico Pharma Vertriebs Gmbh | Neue, Chelatbildner enthaltende Arzneimittel |
| EP1129715A1 (de) * | 2000-02-25 | 2001-09-05 | Werner Dr. Reichen | Anwendung von Magnesium, Kalzium und Silizium zur Heilung verschiedener Krankheiten und zum allgemeinen Wohlbefinden |
-
2003
- 2003-04-08 ES ES200300828A patent/ES2216709B1/es not_active Expired - Fee Related
-
2004
- 2004-04-05 DE DE602004002718T patent/DE602004002718T2/de not_active Expired - Lifetime
- 2004-04-05 AT AT04075998T patent/ATE342060T1/de not_active IP Right Cessation
- 2004-04-05 EP EP04075998A patent/EP1475096B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1475096A1 (de) | 2004-11-10 |
| EP1475096B1 (de) | 2006-10-11 |
| ES2216709B1 (es) | 2005-08-01 |
| ES2216709A1 (es) | 2004-10-16 |
| DE602004002718T2 (de) | 2007-08-16 |
| ATE342060T1 (de) | 2006-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0508579A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0513121A (pt) | composição inseticida sinérgica e processo de preparação de composição inseticida sinérgica | |
| BRPI0408681A (pt) | compostos, composições farmacêuticas, uso de um derivado da 1,2,3,4-tetraidroisoquinolina, método para tratar ou prevenir doenças, processo para a manufatura de composições farmacêuticas, e, uso de um ou mais compostos | |
| BR0316532A (pt) | Composições farmacêuticas compreendendo, um composto de droga básico, respectivamente um ácido, um tensoativo e um ácido solúvel em água fisiologicamente tolerável, respectivamente, uma base | |
| UY27755A1 (es) | Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores. | |
| CY1115825T1 (el) | Φαρμακευτικες συνθεσεις που περιεχουν λεβετιρακεταμη και διαδικασια παρασκευης τους | |
| CY1112139T1 (el) | Μια φαρμακευτικη συνθεση περιλαμβανουσα κρυσταλλικη ριτοναβιρη μορφη ιι και ενα παρασκευασμα εξ αυτης | |
| BR0312573A (pt) | Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina | |
| IL150986A0 (en) | 1,2,3,4,- tetrahydroisoquinoline derivatives | |
| MX347617B (es) | Formulaciones galenicas de compuestos organicos. | |
| CA2366702A1 (en) | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents | |
| BR0116237A (pt) | Compostos, composições farmacêuticas, uso de qualquer um ou mais compostos, e, processo para a manufatura de composições farmacêuticas | |
| NO20022442D0 (no) | Legemidler for sykdommer i forbindelse med reduksjon i benmasse | |
| WO2007064968A3 (en) | Stable pharmaceutical compositions of 5,10 methylenetetrahydrofolate | |
| BR0210122A (pt) | Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo | |
| BR0111358A (pt) | Compostos de tioacetamida e seu uso | |
| BR0309343A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas | |
| SG146648A1 (en) | Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation | |
| NO20000466L (no) | Farmasøytisk preparat for sure, lipofile forbindelser i form av en selvregulerende formulering | |
| IS2789B (is) | Lyfjablöndur sem innihalda mónóamínoxídasa B hemla | |
| AR044200A1 (es) | Composicion de fondaparinux sodico de alta pureza ,un procedimiento de preparacion de esta composicion y composiciones farmaceuticas que la contienen como principio activo | |
| BRPI0414948A (pt) | derivados de pirazolo-e-imidazo pirimidina | |
| BG108180A (en) | Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases | |
| BRPI0409818A (pt) | compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos | |
| BR0315320A (pt) | Composto ou sais farmaceuticamente aceitáveis dos mesmos, uso de um composto, composição farmacêutica, e, métodos para a terapia de dor em um animal de sangue quente e para produzir um composto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |